BONUS VIRTUAL PROGRAM exclusively for the North Suburban Pharmacists of Chicagoland by Pharmacy Times. 2nd Notice.

Optimizing Care of Patients on Immune Checkpoint Inhibitors: An Oncology Primer for Community Pharmacists.

December 1st, 2022. 7:30PM. Virtual program.

This program is open to all NSP members, subscribers, and pharmacy students.

The direct link to register through Pharmacy Times is below:

https://forms.gle/haFCegFBKhBWmAFU8

 ------------------------------------------------------------------------------------------------

PTCE in association with the North Suburban Pharmacists invites you to a Live Free virtual Accredited Presentation

EDUCATIONAL OBJECTIVES

After completion of this activity, participants will be able to:

• Identify the various mechanisms of action of FDA[1]approved immune checkpoint inhibitors (ICIs) and how they work as monotherapy and in synergy with other agents to treat cancer

• Explore FDA-approved indications as well as safety and efficacy data for ICIs in cancer treatment

• Distinguish immune-related adverse effects of ICIs from toxicities of traditional cytotoxic chemotherapy

• Apply special considerations for patients receiving ICI therapies to the safe and effective provision of preventive care, supportive care, and toxicity management in the community pharmacy setting

FACULTY

Jacob K. Kettle, PharmD, BCOP Director, Ellis Fischel Cancer Center University of Missouri Health Care Columbia, Missouri Optimizing Care of Patients on Immune Checkpoint Inhibitors: An Oncology Primer for Community Pharmacists

REGIONAL MEETING

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.25 contact hours (0.125 CEU) under the ACPE universal activity number 0290-0000-22-567-L01-P. The activity is available for CE credit through February 1, 2023.

The direct link to register through Pharmacy Times is below:

https://forms.gle/haFCegFBKhBWmAFU8